Free Trial
OTCMKTS:AMBBY

Ambu A/S 11/5/2024 Earnings Results & Report

Ambu A/S logo
$11.00 0.00 (0.00%)
As of 10/9/2026

Ambu A/S reported earnings on November 5, 2024. The company reported EPS of -$0.08, while revenue was $204.32 million.

Earnings Announcement Details

Report Date
Time
Before Market Opens

Ambu A/S EPS Results

Actual EPS
-$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ambu A/S Revenue Results

Actual Revenue
$204.32 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Ambu A/S Earnings FAQ

Ambu A/S (OTCMKTS:AMBBY) reported earnings of -$0.08 per share for the quarter. The report was announced on Tuesday, November 5, 2024.

Ambu A/S reported revenue of $204.32 million for the quarter.

Ambu A/S Earnings Headlines

Ambu AS ADR AMBBY
3 European Stocks Estimated To Be Undervalued By Up To 47.6%
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
European Growth Companies With Up To 34% Insider Ownership
See More Ambu A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email.

About Ambu A/S

Ambu A/S (OTCMKTS:AMBBY) is a Danish medical device company that develops, manufactures and markets single-use products for hospitals, clinics and emergency care providers. Its portfolio includes disposable endoscopes and visualization systems used in areas such as bronchoscopy, gastrointestinal procedures, urology, ear, nose and throat care, and anesthesia.

The company also supplies products for airway management, patient monitoring and emergency care, including electrodes, resuscitation equipment and training manikins. Ambu’s single-use products are designed to support infection prevention, simplify clinical workflows and reduce the need for reprocessing reusable equipment.

Founded in 1937, Ambu has its headquarters in Ballerup, Denmark, and serves healthcare customers internationally through operations and distribution networks across Europe, North America, the Asia-Pacific region and other global markets. The company is led by Chief Executive Officer Britt Meelby Jensen.

View Ambu A/S Profile